Advancis Pharmacautical enters marketing agreement with Innovex

Advancis Pharmaceutical Corporation has entered into a two-year sales and marketing agreement with Innovex for 75 sales reps to promote Advancis' recently approved cephalosporin antibiotic Keflex (cephalexin). Promotion of Keflex was scheduled to begin in mid-July.
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.